# Amgen Inc. (AMGN) — Q1-2022 Earnings Results

**Report date:** 2022-04-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2022

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.43%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.25 | N/A | +0.81% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's performance. They emphasized the strength of their existing products and future pipeline.

**Key quotes:**

> Management highlighted the resilience of their product portfolio.

> They expressed confidence in ongoing research and development efforts.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock declined slightly by 0.43%, possibly due to a lack of revenue data and no updated guidance. Investors may be cautious as the company did not provide specific future expectations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2022_